Universal CAR-T cells (multiple myeloma)

CAR-T cell therapy · Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal CAR-T cells (multiple myeloma), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Universal CAR-T Cells Targeting Multiple Myeloma [Phase 1]